MD PhDDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the NetherlandsRotterdam, Zuid-Holland, Netherlands
PB0983 - Frequency of discontinuation of vitamin K antagonists and occurrence of bleeding and thromboembolic events in long-term users with a limited life expectancy
Tuesday, June 25, 202413:45 – 14:45 ICT
PB0981 - Vitamin K antagonist treatment quality in the last year of life: a multicentre observational cohort